[PDF] Top 20 MRI based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer

... starting neoadjuvant chemotherapy in patients with breast cancer is to de- crease tumor ...individual response to NAC re- mains difficult. Enabling response prediction ... See full document

... studying MRI-based response pat- terns looked at MRI-based response patterns after ...same MRI-based response categories ex- cept they did not include ... See full document

... Conclusions Patients with breast cancer who achieve pCR with NAC have a significantly improved prognosis and disease-free survival; however, only 10–50% of NAC recipients will achieve a full ... See full document

... rs1042713 can predict pCR to taxane- and platinum-based neoadjuvant chemotherapy in ...BC patients who received epirubicin-based neoadjuvant chemotherapy; ... See full document

... to predict tumor cellularity at the conclusion of ...separate patients who went on to achieve pathologic complete response from those who did not (P = ...quantitative MRI data into a simple ... See full document

... Abstract: Neoadjuvant Chemotherapy is given intravenously during the treatment of breast ...suggest chemotherapy to deflate the large size of encroaching ...the pathological ... See full document

... With Response to Neoadjuvant Chemotherapy Considering that the HLA-DR expression in T lymphocyte populations allows the distinction of axillary lymph node invasion status, we asked if this trait ... See full document

... could predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in women with luminal-type ...alterations during multiple steps in the process ... See full document

... end-of-treatment MRI were per- formed in our patient group. It is plausible patients whose tumours respond well at MRI after only 3–4 cy- cles are very likely to have good nodal response, but ... See full document

... to predict outcome to NAC treatment after an interim MRI ...which patients are likely to have a pCR as opposed to minimal residual disease at completion, whereas FTV measures were not able to make ... See full document

... status-based breast cancer molecular subtypes in correlation with pathology ...of patients is simply not adequate to draw meaningful conclusions in early discrimination of pCR and non-pCR or ... See full document

... Introduction MRI modality is the best technique used in the diagnosis and treatment planning of breast ...of response during the neoadjuvant chemotherapy ...DCE-MRI ... See full document

... here can potentially be used for other solid tumors, although thresholding based on vascular staining and tumor types may need to be optimized for ...to predict response has been examined and ... See full document

... small patients’ population which might weaken the statistical power of the study and might bring about incon- clusive and imprecise ...Second, patients with different breast cancer subtypes ... See full document

... of breast cancer, which are increasingly used for predicting the pathological response to NACT, are related to histological grade and proliferative ...Triple-negative breast ... See full document

... Historically, patients with locally advanced disease have been treated with radical mastectomy if technically ...1040 patients with breast ...satellite breast skin nodules, intercostals or ... See full document

... early response to NACT was a predictor of DFS using data from a retrospective ...and patients to predict long-term ...among patients with cervical cancer who are treated with NACT and ... See full document

... (See figure on previous page.) Fig. 3 AAGAB is a promising on-treatment biomarker of chemotherapy response and outcome. a CART analysis identified AAGAB as a possible biomarker from the Edinburgh NEO ... See full document

... disease can have up to 50% reduction in tumor volume, and indeed only two patients in this study had an equal or increased tumor size after ...all patients had a biological effect of the treatment ... See full document

... Discussion Neoadjuvant chemotherapy is used to treat increasing numbers of women with breast cancer, especially those with locally advanced ...Selecting patients most likely to derive ... See full document